Ticker

Vitalhub Corp. (TSE: VHI - Get Free Report) has earned a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among

Vitalhub Corp. (VHI:CA) Q4 2025 Earnings Call Transcript

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that it has updated the date for the release of its financial results for the fourth quarter and year ended December 31, 2025.

Dallas, Texas, March 10, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $53.2 million, or $1.86 per share, in the fourth quarter of 2025 compared to net income of $22.8 million, or $.80 per share, in the fourth quarter of 2024. For the full year of 2025, Valhi reported a net loss attributable to Valhi stockholders of $57.6 million, or $2.02 per share,…

TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health (“Novari”), a VitalHub company, and Niagara Health are building upon an existing partnership by implementing Novari's Medical Imaging Requisition Management (“MIRM”) and eRequest referral management technologies across the Niagara Region.